Energesis Pharmaceuticals

Energesis Pharmaceuticals is developing therapeutics for diabetes, obesity, and lipid disorders by targeting brown adipose tissue (BAT). The Companys approach is a novel strategy leveraging recent scientific insights in BAT biology to increase the bodys ability to burn stored fat and lower insulin resistance. Diabetes and its major underlying cause... , obesity, have reached epidemic proportions in the U.S. and the rest of the industrialized world. However, there are presently very few safe and effective non-invasive treatments for obesity available, and new approaches for diabetes are needed. The company's technology is the first to enable free slots the development of drugs that increase energy expenditure, a strategy for addressing both obesity and diabetes that is strongly supported by the scientific literature. The Energesis management team brings a strong entrepreneurial record together with world-class scientific farmacia maschile, medical, and product development expertise and casinos reviews will leverage the Companys discovery platform to develop a new generation of agents to effectively treat metabolic disease.Read More